​

Kyntra Bio (KYNB) Stock Forecast, Price Target & Predictions

OverviewRevenueFinancialsChartTranscripts

KYNB Stock Forecast

Kyntra Bio (KYNB) stock forecast, based on 15 Wall Street analysts, predicts a 12-month average price target of $28.00, with a high of $28.00 and a low of $28.00. This represents a 301.72% increase from the last price of $6.97.

$5 $10 $15 $20 $25 $30 High: $28 Avg: $28 Low: $28 Last Closed Price: $6.97

KYNB Stock Rating

Kyntra Bio stock's rating consensus is Hold, based on 15 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (33.33%), 8 Hold (53.33%), 2 Sell (13.33%), and 0 Strong Sell (0.00%).

Hold
Total 15 0 2 8 5 Strong Sell Sell Hold Buy Strong Buy

KYNB Price Target Upside V Benchmarks

TypeNameUpside
StockKyntra Bio301.72%
SectorHealthcare Stocks 15.45%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$6.97$6.97$6.97
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 26--1--1
Jan, 26--1--1
Dec, 251-1--2
Nov, 251-1--2
Oct, 251-1--2
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 02, 2023Annabel SamimyStifel Nicolaus$28.00$17.3261.66%301.72%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 07, 2025H.C. WainwrightBuyBuyhold
Jul 31, 2024William BlairMarket PerformMarket Performhold
Jan 30, 2023William BlairOutperformupgrade
Jan 05, 2023Bank of America SecuritiesBuyupgrade

Financial Forecast

EPS Forecast

$-25 $-20 $-15 $-10 $-5 $0 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.48----
Avg Forecast$-20.00$-4.60$-11.95$-14.65$-8.41
High Forecast$-19.57$-4.51$-6.51$-9.16$-8.23
Low Forecast$-20.43$-4.70$-17.39$-20.14$-8.59
Surprise %-97.60%----

Revenue Forecast

$0 $40M $80M $120M $160M $200M Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$29.62M----
Avg Forecast$177.85M$6.59M$6.12M$6.12M$6.20M
High Forecast$180.77M$6.83M$6.22M$6.13M$6.30M
Low Forecast$174.93M$6.34M$6.02M$6.11M$6.10M
Surprise %-83.34%----

Net Income Forecast

$-85M $-71M $-57M $-43M $-29M $-15M Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-47.58M----
Avg Forecast$-80.04M$-18.42M$-53.75M$-52.30M$-33.65M
High Forecast$-78.33M$-18.03M$-26.05M$-36.64M$-32.94M
Low Forecast$-81.74M$-18.82M$-69.58M$-80.60M$-34.37M
Surprise %-40.55%----

KYNB Forecast FAQ

Is Kyntra Bio stock a buy?

Kyntra Bio stock has a consensus rating of Hold, based on 15 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 8 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that Kyntra Bio is a neutral investment for most analysts.

What is Kyntra Bio's price target?

Kyntra Bio's price target, set by 15 Wall Street analysts, averages $28 over the next 12 months. The price target range spans from $28 at the low end to $28 at the high end, suggesting a potential 301.72% change from the previous closing price of $6.97.

How does Kyntra Bio stock forecast compare to its benchmarks?

Kyntra Bio's stock forecast shows a 301.72% upside, outperforming the average forecast for the healthcare stocks sector (15.45%).

What is the breakdown of analyst ratings for Kyntra Bio over the past three months?

  • February 2026: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • December 2025: 50.00% Strong Buy, 0% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.

What is Kyntra Bio’s EPS forecast?

Kyntra Bio's average annual EPS forecast for its fiscal year ending in December 2025 is $-4.6, marking a 858.33% increase from the reported $-0.48 in 2024. Estimates for the following years are $-11.95 in 2026, $-14.65 in 2027, and $-8.41 in 2028.

What is Kyntra Bio’s revenue forecast?

Kyntra Bio's average annual revenue forecast for its fiscal year ending in December 2025 is $6.59M, reflecting a -77.77% decrease from the reported $29.62M in 2024. The forecast for 2026 is $6.12M, followed by $6.12M for 2027, and $6.2M for 2028.

What is Kyntra Bio’s net income forecast?

Kyntra Bio's net income forecast for the fiscal year ending in December 2025 stands at $-18.424M, representing a -61.28% decrease from the reported $-47.579M in 2024. Projections indicate $-53.75M in 2026, $-52.3M in 2027, and $-33.655M in 2028.